Viewing Study NCT07158918


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-01-15 @ 2:44 PM
Study NCT ID: NCT07158918
Status: RECRUITING
Last Update Posted: 2025-09-08
First Post: 2025-08-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
Sponsor: ABL Bio, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module